This inventor holds 1 USPTO granted patent. Top assignee: Warner-Lambert Company. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Gerald David Nordblom: Innovator in Excitatory Amino Acid Antagonists
Introduction
Gerald David Nordblom is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of pharmacology, particularly in the development of novel compounds that serve as excitatory amino acid antagonists. His work has implications for both therapeutic applications and immunological assays.
Latest Patents
Gerald David Nordblom holds a patent for "Excitatory amino acid antagonists: fused-azacyclic quinoxalinediones." This invention discloses novel fused-azacyclic quinoxalinediones, which may be employed as excitatory amino acid antagonists and as analogs for use in immunological assays. The patent also covers both a radioimmunoassay and enzyme immunoassay for detecting and quantitating 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]-quinoxaline-2,3-dione (PNQX) and its analogs. He has 1 patent to his name.
Career Highlights
Gerald has worked with Warner-Lambert Company, where he has been able to apply his innovative ideas in a corporate setting. His research has contributed to advancements in the understanding and application of excitatory amino acid antagonists.
Collaborations
Throughout his career, Gerald has collaborated with notable colleagues, including Christopher Franklin Bigge and Chung Stephen Yi. These collaborations have likely enriched his research and contributed to the success of his inventions.
Conclusion
Gerald David Nordblom is a distinguished inventor whose work in excitatory amino acid antagonists has made a significant impact in the field of pharmacology. His innovative contributions continue to influence research and applications in immunological assays.